These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6258048)

  • 1. Lack of cross-tolerance on multiple opiate receptors in the mouse vas deferens.
    Schulz R; Wüster M; Krenss H; Herz A
    Mol Pharmacol; 1980 Nov; 18(3):395-401. PubMed ID: 6258048
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of dynorphin-selective Kappa receptors in mouse vas deferens and guinea pig ileum. Spare receptor fraction as a determinant of potency.
    Cox BM; Chavkin C
    Mol Pharmacol; 1983 Jan; 23(1):36-43. PubMed ID: 6135144
    [No Abstract]   [Full Text] [Related]  

  • 3. Lack of cross-tolerance between morphine and Leu-enkephalin in the mouse vas deferens.
    Illes P; Zieglgänsberger W; Herz A
    Brain Res; 1980 Sep; 197(1):260-3. PubMed ID: 6249458
    [No Abstract]   [Full Text] [Related]  

  • 4. Opiate agonists inhibit noradrenaline release via opiate B-receptors and N-cyclopropylmethylnorazidomorphine (CAM) blocks electrically evoked contractions via histamine in the mouse vas deferens.
    Knoll J; Kerecsen L; Somogyi GT; Kovács A
    Arch Int Pharmacodyn Ther; 1981 May; 251(1):52-65. PubMed ID: 6266359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opiate tolerance and cross-tolerance in the mouse vas deferens [proceedings].
    Marshall I; Nasmyth PA; Phillips DG
    Br J Pharmacol; 1979 May; 66(1):131P-132P. PubMed ID: 454927
    [No Abstract]   [Full Text] [Related]  

  • 6. The development of acute tolerance to analgesia and the sensitivity changes in mouse vas deferens and ileum produced by morphine.
    Ramaswamy S; Pillai NP; Gopalakrishnan V; Ghosh MN
    Arch Int Pharmacodyn Ther; 1983 Feb; 261(2):214-21. PubMed ID: 6838282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly specific opiate receptors for dynorphin-(1-13) in the mouse vas deferens.
    Wüster M; Schulz R; Herz A
    Eur J Pharmacol; 1980 Mar; 62(2-3):235-6. PubMed ID: 6103811
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative studies of 2 methods for the quantitative measurement of endorphins in the cerebrospinal fluid. The mouse vas deferens and opiate-receptor binding].
    Laorden ML; Olaso MJ; Miralles F; Puig MM
    Arch Farmacol Toxicol; 1983 Aug; 9(2):165-70. PubMed ID: 6318675
    [No Abstract]   [Full Text] [Related]  

  • 9. Selective development of tolerance without dependence in multiple opiate receptors of mouse vas deferens.
    Schulz R; Wüster M; Krenss H; Herz A
    Nature; 1980 May; 285(5762):242-3. PubMed ID: 6246447
    [No Abstract]   [Full Text] [Related]  

  • 10. Lack of irreversible antagonism of opioid & receptors by [D-ala2,Leu5,Cys6] enkephalin in the mouse isolated vas deferens preparation.
    Wild KD; Jiang Q; Iannone M; Bowen W; Porreca F
    NIDA Res Monogr; 1990; 105():402-3. PubMed ID: 1652085
    [No Abstract]   [Full Text] [Related]  

  • 11. Naloxone antagonizes the action of low ethanol concentrations on mouse vas deferens.
    Blum K; Briggs AH; DeLallo L; Elston SF; Hirst M
    Subst Alcohol Actions Misuse; 1980; 1(4):327-34. PubMed ID: 7302784
    [No Abstract]   [Full Text] [Related]  

  • 12. Proceedings: Assessment of the agonist and antagonist activities of narcotic analgesic drugs by means of the mouse vas deferens.
    Hughes J; Kosterlitz HW; Leslie FM
    Br J Pharmacol; 1974 May; 51(1):139P-140P. PubMed ID: 4155332
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].
    Ananthan S; Khare NK; Saini SK; Seitz LE; Bartlett JL; Davis P; Dersch CM; Porreca F; Rothman RB; Bilsky EJ
    J Med Chem; 2004 Mar; 47(6):1400-12. PubMed ID: 14998329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional opiate receptors in the guinea-pig ileum: their differentiation by means of selective tolerance development.
    Schulz R; Wüster M; Rubini P; Herz A
    J Pharmacol Exp Ther; 1981 Nov; 219(2):547-50. PubMed ID: 6270313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of enkephalin and endorphin analogs on receptors in the mouse vas deferens.
    Britton DR; Fertel R; Coy DH; Kastin AJ
    Biochem Pharmacol; 1978; 27(18):2275-7. PubMed ID: 215153
    [No Abstract]   [Full Text] [Related]  

  • 16. Opioid peptides derived from pre-proenkephalin B sequence: biological evaluation in guinea pig ileum and mouse vas deferens.
    Sánchez-Blázquez P; Garzón J; Lee NM
    Proc West Pharmacol Soc; 1983; 26():85-8. PubMed ID: 6688470
    [No Abstract]   [Full Text] [Related]  

  • 17. Functional opiate receptor in mouse vas deferens: evidence for a complex interaction.
    Sánchez-Blázquez P; Garzón J; Lee NM
    J Pharmacol Exp Ther; 1983 Sep; 226(3):706-11. PubMed ID: 6310079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of biological activities of enkephalin analogues in isolated organs.
    Friedmann T; Medzihradszky K; Kovács A; Kerecsen L; Szécsi JH; Di Gléria K; Knoll J
    Pol J Pharmacol Pharm; 1982; 34(1-3):53-61. PubMed ID: 6300815
    [No Abstract]   [Full Text] [Related]  

  • 19. Naloxone elicits an excitatory response in the morphine-tolerant mouse vas deferens.
    Vargas ML; Musacchio JM; Bansinath M; Turndorf H; Puig MM
    Neuropharmacology; 1987 Dec; 26(12):1815-8. PubMed ID: 3437943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic drug treatment on the sensitivity of mouse vas deferens to drugs.
    McCulloch CR; Pollock D
    Eur J Pharmacol; 1985 Dec; 118(3):253-61. PubMed ID: 4085557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.